Mild soreness at the site for a day or two afterwards is normal and feels similar to the morning after a tetanus or flu jab
Subcutaneous administration works well for self-injection, using the same techniques employed for semaglutide
The regulatory distinction you made is so crucial: the July FDA advisory committee meeting on BPC-157, TB-500, KPV, and others is about compounding access through the 503A pathway, not approval, and not evidence of efficacy
Our injections use hydroxocobalamin, the form recommended by the NHS for treating B12 deficiency anaemia
doi: 10.1016/j.micron.2007.06.009, 246
Memory-like CD8+ and CD4+ T cells cooperate to break peripheral tolerance under lymphopenic conditions